Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified. more
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | 2.64% | -0.53% |
| 1-Month Return | 0.66% | -0.57% |
| 3-Month Return | 4.18% | 13.51% |
| 6-Month Return | -11.24% | 8.45% |
| 1-Year Return | 22.84% | 23.99% |
| 3-Year Return | 23.33% | 71.69% |
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | 289.12% | -24.20% |
| 1-Month Return | 8.33% | -6.72% |
| 3-Month Return | 18.07% | 67.18% |
| 6-Month Return | -21.48% | 17.88% |
| 1-Year Return | 22.84% | 23.99% |
| 3-Year Return | 7.24% | 19.74% |
| Stock name | Ticker | Weight |
|---|---|---|
Novo Nordisk A/S | NVO | 12.46% |
Eli Lilly & Co | LLY | 12.4% |
Pfizer Inc | PFE | 7.13% |
Kailera Therapeutics Inc | KLRA | 5.99% |
CSPC Pharmaceutical Group Ltd | 1093.HK | 5.62% |
Chugai Pharmaceutical Co Ltd | 4519.T | 4.89% |
Viking Therapeutics Inc | VKTX | 4.86% |
Ascletis Pharma Inc | 1672.HK | 4.15% |
Zealand Pharma A/S | ZEAL.CO | 4.11% |
Hanmi Pharm Co Ltd | 128940.KS | 4.06% |
Amgen Inc | AMGN | 3.83% |
AstraZeneca PLC | AZN | 3.77% |
Roche Holding AG | ROP.SW | 3.12% |
United Laboratories International Holdings Ltd/The | 3933.HK | 2.77% |
Hansoh Pharmaceutical Group Co Ltd | 3692.HK | 2.75% |
Structure Therapeutics Inc | GPCR | 2.7% |
Jiangsu Hengrui Pharmaceuticals Co Ltd | 1276.HK | 2.61% |
Innovent Biologics Inc | 1801.HK | 2.43% |
MBX Biosciences Inc | MBX | 2.33% |
Gubra A/S | GUBRA.CO | 2.14% |
Gilead Sciences Inc | GILD | 1.81% |
Rhythm Pharmaceuticals Inc | RYTM | 1.52% |
Shionogi & Co Ltd | 4507.T | 1.36% |
WaVe Life Sciences Ltd | WVE | 0.98% |
First American Government Obligations Fund 12/01/2031 | FGXXX | 0.76% |
Cash & Other | Cash...Other | -0.01% |
SWISS FRANC | CHF | -0.54% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Roundhill Glp-1 & Weight Loss ETF (OZEM) share price today is $31.2879.
Yes, Indians can buy shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. To buy OZEM from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. You can start investing in Roundhill Glp-1 & Weight Loss ETF (OZEM) with a minimum investment of $1.
The 52-week high price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $37.15. The 52-week low price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $22.95.
The stock symbol (or ticker) of Roundhill Glp-1 & Weight Loss ETF is OZEM.
Yes, you can setup SIP in Roundhill Glp-1 & Weight Loss ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of OZEM on the Vested app.
The expense ratio of Roundhill Glp-1 & Weight Loss ETF (OZEM) is 0.59%.
Link copied